125 related articles for article (PubMed ID: 29487706)
1. Clinical, prognostic, and therapeutic significance of heat shock protein 27 in bladder cancer.
Lee MS; Lee J; Lee S; Yoo SM; Kim JH; Kim WT; Kim WJ; Park J
Oncotarget; 2018 Jan; 9(8):7961-7974. PubMed ID: 29487706
[TBL] [Abstract][Full Text] [Related]
2. Small interference RNA targeting heat-shock protein 27 inhibits the growth of prostatic cell lines and induces apoptosis via caspase-3 activation in vitro.
Rocchi P; Jugpal P; So A; Sinneman S; Ettinger S; Fazli L; Nelson C; Gleave M
BJU Int; 2006 Nov; 98(5):1082-9. PubMed ID: 16879439
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein expression independently predicts clinical outcome in prostate cancer.
Cornford PA; Dodson AR; Parsons KF; Desmond AD; Woolfenden A; Fordham M; Neoptolemos JP; Ke Y; Foster CS
Cancer Res; 2000 Dec; 60(24):7099-105. PubMed ID: 11156417
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.
Andrieu C; Taieb D; Baylot V; Ettinger S; Soubeyran P; De-Thonel A; Nelson C; Garrido C; So A; Fazli L; Bladou F; Gleave M; Iovanna JL; Rocchi P
Oncogene; 2010 Apr; 29(13):1883-96. PubMed ID: 20101233
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-203 Is a Prognostic Indicator in Bladder Cancer and Enhances Chemosensitivity to Cisplatin via Apoptosis by Targeting Bcl-w and Survivin.
Zhang X; Zhang Y; Liu X; Fang A; Li P; Li Z; Liu T; Yang Y; Du L; Wang C
PLoS One; 2015; 10(11):e0143441. PubMed ID: 26599571
[TBL] [Abstract][Full Text] [Related]
6. The molecular and clinical verification of therapeutic resistance via the p38 MAPK-Hsp27 axis in lung cancer.
Liu CL; Chen SF; Wu MZ; Jao SW; Lin YS; Yang CY; Lee TY; Wen LW; Lan GL; Nieh S
Oncotarget; 2016 Mar; 7(12):14279-90. PubMed ID: 26872057
[TBL] [Abstract][Full Text] [Related]
7. Intravesically administered antisense oligonucleotides targeting heat-shock protein-27 inhibit the growth of non-muscle-invasive bladder cancer.
Hadaschik BA; Jackson J; Fazli L; Zoubeidi A; Burt HM; Gleave ME; So AI
BJU Int; 2008 Aug; 102(5):610-6. PubMed ID: 18384625
[TBL] [Abstract][Full Text] [Related]
8. Hsp27: a novel therapeutic target for pediatric M4/M5 acute myeloid leukemia.
Yang L; Cao L; Yang M; Tang D; Kang R; Min X; Zhu S; Yu Y
Oncol Rep; 2013 Apr; 29(4):1459-66. PubMed ID: 23404246
[TBL] [Abstract][Full Text] [Related]
9. Heat-shock protein expression in cisplatin-sensitive and -resistant human tumor cells.
Hettinga JV; Lemstra W; Meijer C; Los G; de Vries EG; Konings AW; Kampinga HH
Int J Cancer; 1996 Sep; 67(6):800-7. PubMed ID: 8824551
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 27 is a potential indicator for response to YangZheng XiaoJi and chemotherapy agents in cancer cells.
Owen S; Zhao H; Dart A; Wang Y; Ruge F; Gao Y; Wei C; Wu Y; Jiang WG
Int J Oncol; 2016 Nov; 49(5):1839-1847. PubMed ID: 27600495
[TBL] [Abstract][Full Text] [Related]
11. Heat shock proteins HSP27, HSP60, HSP70, and HSP90: expression in bladder carcinoma.
Lebret T; Watson RW; Molinié V; O'Neill A; Gabriel C; Fitzpatrick JM; Botto H
Cancer; 2003 Sep; 98(5):970-7. PubMed ID: 12942564
[TBL] [Abstract][Full Text] [Related]
12. Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer.
Könsgen D; Klinkmann G; Kaul A; Diesing K; Sehouli J; Braicu I; Sümnig A; Erb HHH; Stope MB; Mustea A
Eur J Obstet Gynecol Reprod Biol; 2020 Dec; 255():154-159. PubMed ID: 33130378
[TBL] [Abstract][Full Text] [Related]
13. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
Zhang Y; Shen X
Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
[TBL] [Abstract][Full Text] [Related]
14. Hsp27, Hsp70 and mismatch repair proteins hMLH1 and hMSH2 expression in peripheral blood lymphocytes from healthy subjects and cancer patients.
Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
Cancer Lett; 2007 Jul; 252(1):131-46. PubMed ID: 17276589
[TBL] [Abstract][Full Text] [Related]
15. Heat shock protein 27 increases after androgen ablation and plays a cytoprotective role in hormone-refractory prostate cancer.
Rocchi P; So A; Kojima S; Signaevsky M; Beraldi E; Fazli L; Hurtado-Coll A; Yamanaka K; Gleave M
Cancer Res; 2004 Sep; 64(18):6595-602. PubMed ID: 15374973
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of heat shock protein 27 (HSP27) in patients with oral squamous cell carcinoma.
Mese H; Sasaki A; Nakayama S; Yoshioka N; Yoshihama Y; Kishimoto K; Matsumura T
Oncol Rep; 2002; 9(2):341-4. PubMed ID: 11836604
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of heat shock proteins in urothelial carcinoma of the urinary bladder.
Yu HJ; Chang YH; Pan CC
Histopathology; 2013 Apr; 62(5):788-98. PubMed ID: 23425286
[TBL] [Abstract][Full Text] [Related]
18. Cooperative interactions between androgen receptor (AR) and heat-shock protein 27 facilitate AR transcriptional activity.
Zoubeidi A; Zardan A; Beraldi E; Fazli L; Sowery R; Rennie P; Nelson C; Gleave M
Cancer Res; 2007 Nov; 67(21):10455-65. PubMed ID: 17974989
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Significance of CREB-Binding Protein and CD81 Expression in Primary High Grade Non-Muscle Invasive Bladder Cancer: Identification of Novel Biomarkers for Bladder Cancer Using Antibody Microarray.
Lee MS; Kim JH; Lee JS; Yun SJ; Kim WJ; Ahn H; Park J
PLoS One; 2015; 10(4):e0125405. PubMed ID: 25915404
[TBL] [Abstract][Full Text] [Related]
20. Small interfering RNA-mediated silencing of heat shock protein 27 (HSP27) Increases chemosensitivity to paclitaxel by increasing production of reactive oxygen species in human ovarian cancer cells (HO8910).
Song TF; Zhang ZF; Liu L; Yang T; Jiang J; Li P
J Int Med Res; 2009; 37(5):1375-88. PubMed ID: 19930842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]